Respiro Diagnostics

£1.0M pre-seed

Announced: Jul 8, 2026
Sector: healthtech
Investors: 6

Summary

Respiro Diagnostics raised £1 million in a pre-seed round to advance its breath-based diagnostic platform for lung cancer and other respiratory diseases. The funding will support clinical research, device development, and the company’s move toward clinical validation.

Investors

Zinc Venture Capital, SFC Capital, Amadeus Capital Partners, Conception X Angel Syndicate, KQ Labs through the Francis Crick Institute, Innovate UK